• SENSEX 72,771.72
    -1,124.02 (--1.52%)
  • BANKNIFTY 54,471.65
    -1,108.75 (--1.99%)
  • NSE
    1,761.00 1,761.00(%)
  • SS Retail
    700.00 603.00(%)
  • Hero Motors
    127.67 80.50(%)
  • Kotak Mah. Bank
    395.80 345.40(%)
  • Aequs
    274.05 274.60(%)
  • Axis Bank
    1,205.00 1,125.50(%)
  • Clean Max Enviro
    1,301.00 728.00(%)
  • Reliance Industries
    1,196.05 1,196.05(%)
  • SBI
    956.30 855.90(%)
  • SBI Nifty 1D RL
    1,057.75 1,059.72(%)
  • HDFC Bank
    718.05 682.00(%)
  • Bharti Airtel
    1,763.60 1,745.00(%)
  • PB Fintech.
    1,135.40 1,115.10(%)
  • Ashok Leyland
    154.80 134.20(%)
  • Interglobe Aviat
    4,845.00 3,894.80(%)
  • ICICI AMC
    3,236.80 3,609.85(%)
  • R Systems Intl.
    282.80 446.55(%)
  • Infosys
    1,009.55 1,727.85(%)
  • Star Health Insu
    550.20 416.85(%)
  • Varun Beverages
    426.30 381.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Accretion Nutraveda Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 96003.0
  • ISIN : INE1KVQ01019
269.80 -2 (-0.72%)
  • As on 28 Sep 2026 (EOD)

  • Today’s Low

    269.05

  • Today’s High

    270.20

  • Open

    270.20

  • Perv Close

    271.75

  • 52W Low

    150.10

  • 52W High

    313.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    195.34

  • Div & Yield %

    0.00

  • Book Value(₹)

    49.00

  • Debt-Equity Ratio

    -0.72

  • AGM Date

    28-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    195.34

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.24

  • BV (₹)

    49.00

  • Sales( ₹ in Cr.)

    33.60

  • NP (in Cr.)

    5.07

  • NP Var(%)

    103.0

  • Div%

    0.0

  • CPS (₹)

    7.40

  • EPS (₹)

    7.00

  • Traded Value (₹ in Lakhs)

    195.34

  • 52 Week High

    313.00

  • 52 Week Low

    150.10

  • Price BSE

    270.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    195.34

  • P/C Ratio

    36.70

  • P/E Ratio

    38.60

  • Price Vs.BV

    7.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar
INCOME :            
Sales Turnover 33.60 16.00 5.01 2.90 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 33.60 16.00 5.01 2.90 - -
Other Income 0.11 0.01 0.19 0.17 - -
Stock Adjustments 0.96 0.95 1.30 0.00 - -
Total Income 34.67 16.96 6.50 3.07 - -
EXPENDITURE :            
Raw Materials 25.07 11.52 4.16 1.70 - -
Power and Fuel Cost 0.14 0.11 0.09 0.04 - -
Employee Cost 0.50 0.23 0.18 0.10 - -
Other Manufacturing Expenses 0.81 0.64 0.32 0.17 - -
Selling and Administration Expenses 1.10 0.71 0.32 0.27 - -
Miscellaneous Expenses 0.05 0.02 0.01 0.00 - -
Employee Benefit Expenses 0.50 0.23 0.18 0.10 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 27.68 13.23 5.08 2.28 - -
Operating Profit 7.00 3.72 1.42 0.79 - -
Interest 0.53 0.35 0.24 0.19 - -
Gross Profit 6.47 3.37 1.18 0.60 - -
Depreciation 0.26 0.22 0.26 0.31 - -
Profit Before Tax 6.21 3.15 0.92 0.29 - -
Current Tax 1.14 0.65 0.10 0.00 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax 0.00 0.00 -0.01 0.01 - -
Reported Net Profit 5.07 2.50 0.82 0.28 - -
Extraordinary Items 0.00 0.00 0.00 0.00 - -
Adjusted Net Profit 5.07 2.50 0.82 0.28 - -
Adjustment below Net Profit -2.72 0.00 0.00 0.00 - -
P & L Balance brought forward 3.04 0.54 -0.10 -0.38 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 5.39 3.04 0.72 -0.10 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 7.00 51.35 22.83 7.79 - -
Earnings Per Share(Adj)-Unit Curr 7.00 - - - - -
Book Value 49.00 103.74 30.14 7.31 - -
Book Value(Adj)-Unit Curr 49.00 - - - - -

Shareholding Pattern

  • Promoter Group

    73.48%

  • Public Share Holding

    26.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,320,000 73.48 5,320,000 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,320,000 73.48 5,320,000 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 78,000 1.08 78,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 442,000 6.11 442,000 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 520,000 7.18 520,000 4
2] Non Institution
Bodies Corporate 147,000 2.03 147,000 9
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5,000 0.07 5,000 2
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 106,000 1.46 106,000 43
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 317,000 4.38 317,000 7
Individuals holding nominal share capital up to Rs. 1 lakh 825,000 11.40 825,000 321
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,400,000 19.34 1,400,000 382
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,240,000 100.00 7,240,000 396

Company Background

Accretion Nutraveda LtdPharmaceuticals - Indian - Formulations

  • Accretion Nutraveda Ltd
  • BSE Code : 96003.0
  • ISIN : INE1KVQ01019

  • Incorporation Year

    2021

  • Registered Office

    27 Xcelon Industrial Park-1
    Vasna-Chacharwadi Ta Sanand, Ahmedabad,
    Gujarat-382213

  • Telephone

    +91 99043 66177

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Payal Hareshbhai Kotadiya

  • Auditor

    VSSB & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Accretion Nutraveda Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Accretion Nutraveda 269.80 33.72 33.60 0.00 27.73
Abbott India 26,758.85 7,217.19 6,929.05 35.22 43.78
Astrazeneca Phar 6,287.50 2,304.07 2,275.58 92.67 27.86
Glaxosmi. Pharma 2,897.85 3,932.76 3,790.20 46.29 58.17
Novartis India 1,935.30 393.10 354.33 48.87 15.94
Cipla 1,388.90 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 737.60 773.53 729.81 68.55 12.51
Amrutanjan Healt 505.15 520.13 502.55 27.06 24.16
Fermenta Biotec. 477.35 474.15 450.25 22.29 18.77
Guj. Themis Bio. 397.45 168.25 165.82 106.27 18.05
Ambalal Sarabhai 39.13 19.52 3.94 72.46 6.77